HLA‐A2‐restricted CTL epitopes of a novel lung cancer‐associated cancer testis antigen, cell division cycle associated 1, can induce tumor‐reactive CTLMichiko Harao, Yasuharu Nishimura, Tetsuya Nakatsura et al.|International Journal of Cancer|2008Cited by 92
Identification of SPARC as a candidate target antigen for immunotherapy of various cancersMitsuhiro Inoue, Yasuharu Nishimura, Satoru Senju et al.|International Journal of Cancer|2010Cited by 39